BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 26103481)

  • 21. Dosimetric properties of an amorphous silicon EPID for verification of modulated electron radiotherapy.
    Chatelain C; Vetterli D; Henzen D; Favre P; Morf D; Scheib S; Fix MK; Manser P
    Med Phys; 2013 Jun; 40(6):061710. PubMed ID: 23718589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Portal dosimetry in wedged beams.
    Spreeuw H; Rozendaal R; Camargo P; Mans A; Wendling M; Olaciregui-Ruiz I; Sonke JJ; Van Herk M; Mijnheer B
    J Appl Clin Med Phys; 2015 May; 16(3):5375. PubMed ID: 26103497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel technique for VMAT QA with EPID in cine mode on a Varian TrueBeam linac.
    Liu B; Adamson J; Rodrigues A; Zhou F; Yin FF; Wu Q
    Phys Med Biol; 2013 Oct; 58(19):6683-700. PubMed ID: 24018655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pretreatment verification of IMRT absolute dose distributions using a commercial a-Si EPID.
    Talamonti C; Casati M; Bucciolini M
    Med Phys; 2006 Nov; 33(11):4367-78. PubMed ID: 17153415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Daily QA of linear accelerators using only EPID and OBI.
    Sun B; Goddu SM; Yaddanapudi S; Noel C; Li H; Cai B; Kavanaugh J; Mutic S
    Med Phys; 2015 Oct; 42(10):5584-94. PubMed ID: 26429233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical experience with EPID dosimetry for prostate IMRT pre-treatment dose verification.
    McDermott LN; Wendling M; van Asselen B; Stroom J; Sonke JJ; van Herk M; Mijnheer BJ
    Med Phys; 2006 Oct; 33(10):3921-30. PubMed ID: 17089854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Testing the portal imager GLAaS algorithm for machine quality assurance.
    Nicolini G; Vanetti E; Clivio A; Fogliata A; Boka G; Cozzi L
    Radiat Oncol; 2008 May; 3():14. PubMed ID: 18495005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Time dependent pre-treatment EPID dosimetry for standard and FFF VMAT.
    Podesta M; Nijsten SM; Persoon LC; Scheib SG; Baltes C; Verhaegen F
    Phys Med Biol; 2014 Aug; 59(16):4749-68. PubMed ID: 25088064
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel method for sub-arc VMAT dose delivery verification based on portal dosimetry with an EPID.
    Cools RAM; Dirkx MLP; Heijmen BJM
    Med Phys; 2017 Nov; 44(11):5556-5562. PubMed ID: 28815696
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative evaluation of 3D dosimetry for stereotactic volumetric-modulated arc delivery using COMPASS.
    Vikraman S; Manigandan D; Karrthick KP; Sambasivaselli R; Senniandavar V; Ramu M; Rajesh T; Lutz M; Muthukumaran M; Karthikeyan N; Tejinder K
    J Appl Clin Med Phys; 2014 Jan; 16(1):5128. PubMed ID: 25679152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of a one-stop beam verification system using electronic portal imaging devices for routine quality assurance.
    Lim S; Ma SY; Jeung TS; Yi BY; Lee SH; Lee S; Cho SJ; Choi J
    Med Dosim; 2012; 37(3):296-304. PubMed ID: 22277157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimization of image quality and dose for Varian aS500 electronic portal imaging devices (EPIDs).
    McGarry CK; Grattan MW; Cosgrove VP
    Phys Med Biol; 2007 Dec; 52(23):6865-77. PubMed ID: 18029980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GLAaS: an absolute dose calibration algorithm for an amorphous silicon portal imager. Applications to IMRT verifications.
    Nicolini G; Fogliata A; Vanetti E; Clivio A; Cozzi L
    Med Phys; 2006 Aug; 33(8):2839-51. PubMed ID: 16964860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluating the sensitivity of Halcyon's automatic transit image acquisition for treatment error detection: A phantom study using static IMRT.
    Ray X; Bojechko C; Moore KL
    J Appl Clin Med Phys; 2019 Nov; 20(11):131-143. PubMed ID: 31587477
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pretreatment verification of IMSRT using electronic portal imaging and Monte Carlo calculations.
    Parker BC; Shiu A; White RA; Maor M; Dong L; Liu HH
    Technol Cancer Res Treat; 2009 Dec; 8(6):413-23. PubMed ID: 19925025
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 2D lag and signal nonlinearity correction in an amorphous silicon EPID and their impact on pretreatment dosimetric verification.
    Warkentin B; Rathee S; Steciw S
    Med Phys; 2012 Nov; 39(11):6597-608. PubMed ID: 23127054
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dosimetric investigation and portal dose image prediction using an amorphous silicon electronic portal imaging device.
    McCurdy BM; Luchka K; Pistorius S
    Med Phys; 2001 Jun; 28(6):911-24. PubMed ID: 11439488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Off-axis dose response characteristics of an amorphous silicon electronic portal imaging device.
    Greer PB
    Med Phys; 2007 Oct; 34(10):3815-24. PubMed ID: 17985627
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A retrospective analysis for patient-specific quality assurance of volumetric-modulated arc therapy plans.
    Li G; Wu K; Peng G; Zhang Y; Bai S
    Med Dosim; 2014; 39(4):309-13. PubMed ID: 24958705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel method for patient exit and entrance dose prediction based on water equivalent path length measured with an amorphous silicon electronic portal imaging device.
    Kavuma A; Glegg M; Metwaly M; Currie G; Elliott A
    Phys Med Biol; 2010 Jan; 55(2):435-52. PubMed ID: 20019398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.